Menveo
meningococcal group A, C, W-135 and Y conjugate vaccine
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Menveo. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Menveo.
Authorisation details
Product details | |
---|---|
Name |
Menveo
|
Agency product number |
EMEA/H/C/001095
|
Active substance |
meningococcal group A, C, W-135 and Y conjugate vaccine
|
International non-proprietary name (INN) or common name |
meningococcal group A, C, W-135 and Y conjugate vaccine
|
Therapeutic area (MeSH) |
|
Anatomical therapeutic chemical (ATC) code |
J07AH08
|
Publication details | |
---|---|
Marketing-authorisation holder |
GSK Vaccines S.r.l.
|
Revision |
33
|
Date of issue of marketing authorisation valid throughout the European Union |
15/03/2010
|
Contact address |
via Fiorentina 1
53100 Siena Italy |
Product information
21/06/2023 Menveo - EMEA/H/C/001095 - IB/0118
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Bacterial vaccines
Therapeutic indication
Vials
Menveo is indicated for active immunisation of children (from two years of age), adolescents and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease.
The use of this vaccine should be in accordance with official recommendations.